Automation, Collaboration and the Future of Advanced Therapies

About this episode

This episode discusses the pressures and advancements in cell and gene therapy manufacturing, focusing on automation and collaboration.

In this episode of Denatured, you'll listen to Jason Jones, head of global business development at Cellular Origins and Alexander Seyf, founder & CEO of Autolomous. They discuss how cell and gene therapy manufacturing is facing growing pressure to scale more quickly and efficiently, driving developers and manufacturers toward automation, digitization, robotics and broader collaboration across the ecosystem. Host Jennifer C. Smith-Parker , Director of Insights, BioSpace Guests Jason Jones , Head of Global Business Development, Cellular Origins Alexander Seyf , Founder & CEO, Autolomous Disclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.

People in this episode

Host: Jennifer C. Smith-Parker

Guests: Jason Jones, Alexander Seyf

Topics covered

• automation
• collaboration
• advanced therapies
• cell therapy
• gene therapy
• manufacturing
• digitization

Keywords

• automation
• cell therapy
• gene therapy
• manufacturing
• digitization
• robotics
• collaboration

Mentioned in this episode

Organizations: Cellular Origins, Autolomous

More episodes of BioSpace

• Portugal, Spain and the new biotech frontier · June 10, 2026 · 21 min
• Lilly tees off with Novo at ADA, GSK’s $10.6B deal, FDA reform continues in Makary’s absence · June 10, 2026 · 25 min
• Rethinking hair loss treatment · June 3, 2026 · 22 min
• ASCO wins from RevMed, Akeso/Summit, more; plus more Lilly and more China; ADA on deck · June 3, 2026 · 27 min
• France’s biotech ecosystem: science, capital and scale · May 28, 2026 · 21 min
• Lilly wheels and deals, Moderna gets boost on hantavirus scare, ASCO excitement builds · May 27, 2026 · 25 min